Literature DB >> 28490461

Quality of life among children with spina bifida in Uganda.

Helen J Sims-Williams1, Hugh P Sims-Williams2, Edith Mbabazi Kabachelor3, Benjamin C Warf4.   

Abstract

BACKGROUND: Children surviving after spina bifida repair often have significant disability, the consequences of which may be more profound in low-income countries. The aim of this cross-sectional study was to measure quality of life (QOL) reported by children with spina bifida in Uganda, and to define factors associated with QOL.
METHODS: QOL was measured using both the Health Utilities Index (HUI3) Tool and a visual analogue scale (VAS) marked from 0 to 10. In keeping with the WHO definition of QOL, further analysis was conducted using subjective QOL scores (using the VAS). Multivariate regression was used to investigate the association between VAS scores and prespecified variables: age, sex, hydrocephalus, mobility, urinary continence, school attendance and family size.
RESULTS: Sixty two of 68 surviving children aged 10-14 were able to complete all aspects of the assessment. There was poor correlation between the VAS and HUI3 Tool (Pearson correlation 0.488). On multivariate regression, the following variables were associated with a significant change in the 10-point VAS (change in score; 95% CI): male sex (-1.45; -2.436 to -0.465), urinary continence (1.681; 0.190 to 3.172), large family size (-1.775; -2.773 to -0.777) and hydrocephalus (-1.382; -2.374 to -0.465).
CONCLUSIONS: Urinary continence and family size are potentially modifiable, the former by simple and inexpensive medical management. Enhanced investment in community-based rehabilitation and support is urgently needed. Delivery of family planning services is a national priority in Uganda, and should be discussed with families as part of holistic care. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Congenital Abnorm; Neurodisability; Neurosurgery; Patient perspective; Tropical Paediatrics

Mesh:

Year:  2017        PMID: 28490461     DOI: 10.1136/archdischild-2016-312307

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  The socioeconomic impact of a pediatric ostomy in Uganda: a pilot study.

Authors:  Arlene Muzira; Nasser Kakembo; Phyllis Kisa; Monica Langer; John Sekabira; Doruk Ozgediz; Tamara N Fitzgerald
Journal:  Pediatr Surg Int       Date:  2018-01-24       Impact factor: 1.827

2.  Neural Tube Defects and Associated Factors among Neonates Admitted to the Neonatal Intensive Care Units in Hiwot Fana Specialized University Hospital, Harar, Ethiopia.

Authors:  Yunus Edris; Hanan Abdurahman; Assefa Desalew; Fitsum Weldegebreal
Journal:  Glob Pediatr Health       Date:  2020-11-13

3.  Renal Outcomes in Children with Operated Spina Bifida in Uganda.

Authors:  Helen J Sims-Williams; Hugh P Sims-Williams; Edith Mbabazi Kabachelor; Benjamin C Warf
Journal:  Int J Nephrol       Date:  2018-08-07

4.  A comparison of self-reported and proxy-reported health utilities in children: a systematic review and meta-analysis.

Authors:  Aixia Ma; Pingyu Chen; Mingyu Jiang; Yue Ma; Minghui Li; Rui Meng
Journal:  Health Qual Life Outcomes       Date:  2021-02-05       Impact factor: 3.186

5.  Are We Agreed? Self- Versus Proxy-Reporting of Paediatric Health-Related Quality of Life (HRQoL) Using Generic Preference-Based Measures: A Systematic Review and Meta-Analysis.

Authors:  Diana Khanna; Jyoti Khadka; Christine Mpundu-Kaambwa; Kiri Lay; Remo Russo; Julie Ratcliffe
Journal:  Pharmacoeconomics       Date:  2022-08-23       Impact factor: 4.558

Review 6.  Preference-based measures of health-related quality of life in congenital mobility impairment: a systematic review of validity and responsiveness.

Authors:  Nathan Bray; Llinos Haf Spencer; Rhiannon Tudor Edwards
Journal:  Health Econ Rev       Date:  2020-04-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.